Business Description
Sihuan Pharmaceutical Holdings Group Ltd
NAICS : 325414
ISIN : BMG8162K1137
Compare
Compare
Traded in other countries / regions
00460.Hong KongSHPHF.USATEL1.Germany IPO Date
2010-10-28Description
Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Respiratory, Neurology, and others. The group has three reportable segments: the medical aesthetic products segment including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others; the innovative medicine and other medicine segments; and the generic medicine segment which generates key revenue. Geographically, the company generates a majority of its revenue from Mainland China and the rest from the United States.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.31 | |||||
| Equity-to-Asset | 0.38 | |||||
| Debt-to-Equity | 0.26 | |||||
| Debt-to-EBITDA | 3.22 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 1.08 | |||||
| Beneish M-Score | -2.63 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -10.8 | |||||
| 3-Year EBITDA Growth Rate | -33.4 | |||||
| 3-Year FCF Growth Rate | 37 | |||||
| 3-Year Book Growth Rate | -23.3 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.96 | |||||
| 9-Day RSI | 47.25 | |||||
| 14-Day RSI | 48.79 | |||||
| 6-1 Month Momentum % | 34.55 | |||||
| 12-1 Month Momentum % | 7.25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.64 | |||||
| Quick Ratio | 1.52 | |||||
| Cash Ratio | 1.18 | |||||
| Days Inventory | 336.75 | |||||
| Days Sales Outstanding | 85.99 | |||||
| Days Payable | 124.44 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.04 | |||||
| 3-Year Dividend Growth Rate | 32.2 | |||||
| Forward Dividend Yield % | 3.04 | |||||
| 5-Year Yield-on-Cost % | 4.38 | |||||
| 3-Year Average Share Buyback Ratio | 0.5 | |||||
| Shareholder Yield % | 5.7 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 65.93 | |||||
| Operating Margin % | -15.2 | |||||
| Net Margin % | -2.14 | |||||
| FCF Margin % | -2.24 | |||||
| ROE % | -0.85 | |||||
| ROA % | -0.32 | |||||
| ROIC % | -5.13 | |||||
| ROC (Joel Greenblatt) % | 4.2 | |||||
| ROCE % | 1.47 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 10.27 | |||||
| PS Ratio | 3.37 | |||||
| PB Ratio | 1.35 | |||||
| Price-to-Tangible-Book | 1.64 | |||||
| Price-to-Operating-Cash-Flow | 28.75 | |||||
| EV-to-EBIT | 18.53 | |||||
| EV-to-EBITDA | 6.41 | |||||
| EV-to-Revenue | 1.27 | |||||
| EV-to-FCF | -56.66 | |||||
| Price-to-Projected-FCF | 0.82 | |||||
| Price-to-Median-PS-Value | 0.62 | |||||
| Earnings Yield (Greenblatt) % | 5.4 | |||||
| FCF Yield % | -0.66 | |||||
| Forward Rate of Return (Yacktman) % | 21.3 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sihuan Pharmaceutical Holdings Group Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 1,902.7 | ||
| EPS (TTM) (HK$) | -0.005 | ||
| Beta | 1.08 | ||
| Volatility % | 37.2 | ||
| 14-Day RSI | 48.79 | ||
| 14-Day ATR (HK$) | 0.038916 | ||
| 20-Day SMA (HK$) | 0.705 | ||
| 12-1 Month Momentum % | 7.25 | ||
| 52-Week Range (HK$) | 0.49 - 1.02 | ||
| Shares Outstanding (Mil) | 9,310 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sihuan Pharmaceutical Holdings Group Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sihuan Pharmaceutical Holdings Group Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sihuan Pharmaceutical Holdings Group Ltd Frequently Asked Questions
What is Sihuan Pharmaceutical Holdings Group Ltd(HKSE:00460)'s stock price today?
The current price of HKSE:00460 is HK$0.69. The 52 week high of HKSE:00460 is HK$1.02 and 52 week low is HK$0.49.
When is next earnings date of Sihuan Pharmaceutical Holdings Group Ltd(HKSE:00460)?
The next earnings date of Sihuan Pharmaceutical Holdings Group Ltd(HKSE:00460) is 2025-03-02 Est..
Does Sihuan Pharmaceutical Holdings Group Ltd(HKSE:00460) pay dividends? If so, how much?
The Dividend Yield %  of Sihuan Pharmaceutical Holdings Group Ltd(HKSE:00460) is 3.04% (As of Today), Highest Dividend Payout Ratio of Sihuan Pharmaceutical Holdings Group Ltd(HKSE:00460) was 0.38. The lowest was 0.11. And the median was 0.26. The  Forward Dividend Yield % of Sihuan Pharmaceutical Holdings Group Ltd(HKSE:00460) is 3.04%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers